Combination of G2-S16 Dendrimer/Dapivirine Antiretroviral as a New HIV-1 Microbicide

References

• Gong E , MatthewsB, McCarthyTet al. Evaluation of dendrimer SPL7013, a lead microbicide candidate against herpes simplex viruses. Antiviral Res.68(3), 139–146 (2005).
   PubMed Web of Science ®Google Scholar
• McGowan I , GomezK, BruderKet al. Phase 1 randomized trial of the vaginal safety and acceptability of SPL7013 gel (VivaGel) in sexually active young women (MTN-004). AIDS25(8), 1057–1064 (2011).
   PubMed Web of Science ®Google Scholar
• Bermejo JF , OrtegaP, ChoncoLet al. Water-soluble carbosilane dendrimers: synthesis biocompatibility and complexation with oligonucleotides; evaluation for medical applications. Chemistry13(2), 483–495 (2007).
   PubMed Web of Science ®Google Scholar
• Ortega P , BermejoJF, ChoncoLet al. Novel water-soluble carbosilane dendrimers: synthesis and biocompatibility. Euro. J. Inorg. Chem.7, 1388–1396 (2006).
   Google Scholar
• Roy U , RodriguezJ, BarberP, das NevesJ, SarmentoB, NairM. The potential of HIV-1 nanotherapeutics: from in vitro studies to clinical trials. Nanomedicine10(24), 3597–3609 (2015).
   PubMed Web of Science ®Google Scholar
• Sepulveda-Crespo D , GomezR, dela Mata FJ, JimenezJL, Munoz-FernandezMA. Polyanionic carbosilane dendrimer-conjugated antiviral drugs as efficient microbicides: recent trends and developments in HIV treatment/therapy. Nanomedicine11(6), 1481–1498 (2015).
   PubMed Web of Science ®Google Scholar
• Whaley KJ , HanesJ, ShattockR, ConeRA, FriendDR. Novel approaches to vaginal delivery and safety of microbicides: biopharmaceuticals, nanoparticles, and vaccines. Antiviral Res.88(Suppl. 1), S55–S66 (2010).
   PubMed Web of Science ®Google Scholar
• Sepulveda-Crespo D , Cena-DiezR, JimenezJL, AngelesMunoz-Fernandez M. Mechanistic studies of viral entry: an overview of dendrimer-based microbicides as entry inhibitors against both HIV and HSV-2 overlapped infections. Med. Res. Rev.37(1), 149–179 (2017).
   PubMed Web of Science ®Google Scholar
• Cena-Diez R , Garcia-BroncanoP, dela Mata FJ, GomezR, Munoz-FernandezMA. Efficacy of HIV antiviral polyanionic carbosilane dendrimer G2-S16 in the presence of semen. Int. J. Nanomedicine11, 2443–2450 (2016).
   PubMed Web of Science ®Google Scholar
• Garcia-Broncano P , Cena-DiezR, dela Mata FJ, GomezR, ResinoS, Munoz-FernandezMA. Efficacy of carbosilane dendrimers with an antiretroviral combination against HIV-1 in the presence of semen-derived enhancer of viral infection. Eur. J. Pharmacol.811, 155–163 (2017).
   PubMed Web of Science ®Google Scholar
• Garcia F , Bernaldode Quiros JC, GomezCEet al. Safety and immunogenicity of a modified pox vector-based HIV/AIDS vaccine candidate expressing Env, Gag, Pol and Nef proteins of HIV-1 subtype B (MVA-B) in healthy HIV-1-uninfected volunteers: a phase I clinical trial (RISVAC02). Vaccine29(46), 8309–8316 (2011).
   PubMed Web of Science ®Google Scholar
• Sanchez-Rodriguez J , Vacas-CordobaE, GomezR, dela Mata FJ, Munoz-FernandezMA. Nanotech-derived topical microbicides for HIV prevention: the road to clinical development. Antiviral Res.113, 33–48 (2015).
   PubMed Web of Science ®Google Scholar
• Vacas Cordoba E , ArnaizE, RellosoMet al. Development of sulphated and naphthylsulphonated carbosilane dendrimers as topical microbicides to prevent HIV-1 sexual transmission. AIDS27(8), 1219–1229 (2013).
   PubMed Web of Science ®Google Scholar
• Chonco L , PionM, VacasEet al. Carbosilane dendrimer nanotechnology outlines of the broad HIV blocker profile. J. Control. Release161(3), 949–958 (2012).
   PubMed Web of Science ®Google Scholar
• Cena-Diez R , Vacas-CordobaE, Garcia-BroncanoPet al. Prevention of vaginal and rectal herpes simplex virus type 2 transmission in mice: mechanism of antiviral action. Int. J. Nanomedicine11, 2147–2162 (2016).
   PubMed Web of Science ®Google Scholar
• Sepulveda-Crespo D , SerramiaMJ, TagerAMet al. Prevention vaginally of HIV-1 transmission in humanized BLT mice and mode of antiviral action of polyanionic carbosilane dendrimer G2-S16. Nanomedicine11(6), 1299–1308 (2015).
   PubMed Web of Science ®Google Scholar
• Teeraananchai S , KerrSJ, AminJ, RuxrungthamK, LawMG. Life expectancy of HIV-positive people after starting combination antiretroviral therapy: a meta-analysis. HIV Med.18(4), 256–266 (2017).
   PubMed Web of Science ®Google Scholar
• Belshe RB , LeonePA, BernsteinDIet al. Efficacy results of a trial of a herpes simplex vaccine. N. Engl. J. Med.366(1), 34–43 (2012).
   PubMed Web of Science ®Google Scholar
• Buckheit RW Jr , WatsonKM, MorrowKM, HamAS. Development of topical microbicides to prevent the sexual transmission of HIV. Antiviral Res.85(1), 142–158 (2010).
   PubMed Web of Science ®Google Scholar
• Murphy DJ , DesjardinsD, Dereuddre-BosquetNet al. Pre-clinical development of a combination microbicide vaginal ring containing dapivirine and darunavir. J. Antimicrob. Chemother.69(9), 2477–2488 (2014).
   PubMed Web of Science ®Google Scholar
• Nel A , HaazenW, NuttallJ, RomanoJ, RosenbergZ, van NiekerkN. A safety and pharmacokinetic trial assessing delivery of dapivirine from a vaginal ring in healthy women. AIDS28(10), 1479–1487 (2014).
   PubMed Web of Science ®Google Scholar
• Winceslaus SJ . Dapivirine vaginal ring for HIV-1 prevention. N. Engl. J. Med.376(10), 994–995 (2017).
   PubMedGoogle Scholar
• Baeten JM , Palanee-PhillipsT, BrownERet al. Use of a vaginal ring containing dapivirine for HIV-1 prevention in women. N. Engl. J. Med.375(22), 2121–2132 (2016).
   PubMed Web of Science ®Google Scholar
• Else LJ , TaylorS, BackDJ, KhooSH. Pharmacokinetics of antiretroviral drugs in anatomical sanctuary sites: the male and female genital tract. Antivir. Ther.16(8), 1149–1167 (2011).
   PubMed Web of Science ®Google Scholar
• Vacas-Cordoba E , GalanM, dela Mata FJ, GomezR, PionM, Munoz-FernandezMA. Enhanced activity of carbosilane dendrimers against HIV when combined with reverse transcriptase inhibitor drugs: searching for more potent microbicides. Int. J. Nanomedicine9, 3591–3600 (2014).
   PubMed Web of Science ®Google Scholar
• Guerrero-Beltran C , Cena-DiezR, Sepulveda-CrespoDet al. Carbosilane dendrons with fatty acids at the core as a new potential microbicide against HSV-2/HIV-1 co-infection. Nanoscale9(44), 17263–17273 (2017).
   PubMed Web of Science ®Google Scholar
• Arnáiz E , Vacas-CordobaE, GalánMet al. Synthesis of anionic carbosilane dendrimers via “click chemistry” and their antiviral properties against HIV. Polym. Chem.52(8), 1099–1112 (2014).
   Web of Science ®Google Scholar
• Sepulveda-Crespo D , Sanchez-RodriguezJ, SerramiaMJet al. Triple combination of carbosilane dendrimers, tenofovir and maraviroc as potential microbicide to prevent HIV-1 sexual transmission. Nanomedicine10(6), 899–914 (2015).
   PubMed Web of Science ®Google Scholar
• Chou TC , TalalayP. Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors. Adv. Enzyme Regul.22, 27–55 (1984).
   PubMedGoogle Scholar
• Chou TC . Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies. Pharmacol. Rev.58(3), 621–681 (2006).
   PubMed Web of Science ®Google Scholar
• Sepulveda-Crespo D , LorenteR, LealMet al. Synergistic activity profile of carbosilane dendrimer G2-STE16 in combination with other dendrimers and antiretrovirals as topical anti-HIV-1 microbicide. Nanomedicine10(3), 609–618 (2014).
   PubMed Web of Science ®Google Scholar
• European Committee for Antimicrobial Susceptibility Testing (EUCAST) of the European Society of Clinical Microbiology and Infectious Dieases (ESCMID) . EUCAST Definitive Document E.Def 1.2, May 2000: Terminology relating to methods for the determination of susceptibility of bacteria to antimicrobial agents. Clin. Microbiol. Infect.6(9), 503–508 (2000).
   PubMed Web of Science ®Google Scholar
• Maeda K , DasD, NakataH, MitsuyaH. CCR5 inhibitors: emergence, success, and challenges. Expert Opin. Emerg. Drugs17(2), 135–145 (2012).
   PubMed Web of Science ®Google Scholar
• Romano J , VarianoB, CoplanPet al. Safety and availability of dapivirine (TMC120) delivered from an intravaginal ring. AIDS Res. Hum. Retroviruses25(5), 483–488 (2009).
   PubMed Web of Science ®Google Scholar
• Woolfson AD , MalcolmRK, MorrowRJ, TonerCF, McCullaghSD. Intravaginal ring delivery of the reverse transcriptase inhibitor TMC 120 as an HIV microbicide. Int. J. Pharm.325(1–2), 82–89 (2006).
   PubMed Web of Science ®Google Scholar